Expression, localization, and significance of vascular permeability/vascular endothelial growth factor in nasal polyps

American Journal of Rhinology

Volumn 19, Issue 1, 2005, Pages 7-13

  Gosepath, Jan ^a,b   Brieger, Juergen ^a   Lehr, Hans Anton ^a   Mann, Wolf J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ANTIBODY DETECTION; ARTICLE; BLOOD VESSEL PERMEABILITY; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; NOSE MUCOSA; NOSE OBSTRUCTION; NOSE POLYP; NOSE RECONSTRUCTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RHINOSINUSITIS; SURGICAL TECHNIQUE;

EID: 15944377411     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.1177/194589240501900102     Document Type: Article

References (35)

1. Kaliner MA, Osguthrope JD, Fireman P, et al. Sinusitis: Bench to bedside. Current findings, future directions. J Allergy Clin Immunol 99:829-848, 1997.
2. National Center of Health Statistics. Vital Health Stat 10:199, 1995.
3. National Center of Health Statistics. Vital Health Stat 10:190, 1994.
4. Larsen PL, Tingsgaard PK, Harcourt J, et al. Nasal polyps and their relation to polyps/hypertrophic polypoid mucosa in the paranasal sinuses. A macro-, endo-, and microscopic study of autopsy materials. Am J Rhinol 247:63-76, 1998.
5. Coste AJG, Rateau F, Roudot-Thoraval C et al. Increased epithelial cell proliferation in nasal polyps. Arch Otolaryngol Head Neck Surg 122:432-436, 1996.
6. Guo J, Wang X, Tao G. Expression of vascular endothelial growth factor and transforming growth factor-beta 1 in nasal polyps. Zhonghua Er Bi Yan Hou Ke Za Zhi 36:83-86, 2001.
7. Coste A, Brugel L, Maitre B, et al. Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor. Eur Respir J 15:367-372, 2000.
8. Jiang S, Dong Z, and Yang Z. Expression and the role of vascular endothelial growth factor mRNA in nasal polyps. Lin Chuang Er Bi Yan Hou Ke Za Zhi 15:339-340, 2001.
9. Ito A, Hirota S, Mizumo H, et al. Expression of vascular permeability factor (VPF/VEGF) messenger RNA by plasma cells: Possible involvement in the development of edema in chronic inflammation. Pathol Int 45:715-720, 1995.
10. Wittekindt C, Hess A, Bloch W, et al. Immunohistochemical expression of VEGF and VEGF receptors in nasal polyps as compared to normal turbinate mucosa. Eur Arch Otorhinolaryngol 259:294-298, 2002.
11. Yang J, Kong H, and Dong Z. Expression and significance of vascular permeability factor in nasal polyps. Zhonghua Er Bi Yan Hou Ke Za Zhi 33:297-298, 1998.
12. Settipane GA. Epidemiology of nasal polyps. Allergy Asthma Proc 17:231-236, 1996.
13. Gosepath J, Hoffmann F, Schaefer D, et al. Aspirin intolerance in patients with chronic sinusitis. ORL J Otorhinolaryngol Spec 3:146-150, 1999.
14. Gosepath J, and Mann WJ. Aspirin intolerance and nasal polyps. Curr Opin 10:3-7, 2002 Feb.
15. Pinto S, Gallo O, Polli G, et al. Cyclooxygenase and lipoxygenase metabolite generation in nasal polyps. Prostaglandins Leukot Essent Fatty Acids 57(6):533-537, 1997.
16. Picado C, Fernandez-Morata JC, Juan M, et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med. 160(1):291-296, 1999.
17. Mullol J, Fernandez-Morata JC, et al. Cyclooxygenase 1 and cyclooxygenase 2 expression is abnormally regulated in human nasal polyps. J Allergy Clin Immunol. 109(5):824-830, 2002.
18. Gosepath J, Brieger J, Gletsou E, and Mann WJ. Expression and localization of cyclo-oxygenases (Cox-1 and Cox-2) in nasal respiratory mucosa. Does Cox-2 play a key role in the immunology of nasal polyps? J Investig Allergol Clin Immunol 14(2): 114-118, 2004.
19. Fujita T, Matsui M, Takaku K, et al. Size and invasion dependent increase in cyclooxygenase-2 levels in human colorectal carcinomas. Cancer Res 58:4823-4826, 1998.
20. Uefuji K, Ichikura T, and Mochizuki H. Expression of cyclooxygenase-2 in human gastric adenomas and adenocarcinomas. J Surg Oncol 71:26-30, 2001.
21. Seno H, Oshima M, Ishikawa TO, et al. Cyclooxygenase-2 and prostaglandin E (2) receptor EP (2)-dependent angiogenesis in APC (Delta 716) mouse intestinal polyps. Cancer Res 62:506-511, 2002.
22. Tsujii M, Kawano S, Tsuji S, et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 87:803-809, 1996.
23. Lehr HA, Mankoff DA, Corwin D, et al. Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem 45:1559-1565, 1997.
24. Lehr HA, Jacobs TW, Yaziji H, et al. Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis. Am J Clin Pathol 115:814-822, 2001.
25. Kawada M, Seno H, Wada M, et al. Cyclooxygenase-2 expression and angiogenesis in gastric hyperplastic polyp - Association with polyp size. Digestion 67:20-24, 2003.
26. Hasegawa K, Ichikawa W, Fujita T, et al. Expression of cyclooxygenase-2 mRNA in human colorectal adenomas. Eur J Cancer 37:1469-1474, 2001.
27. Ristimaki A, Honkanen N, Jankala. H, et al. Expression of cyclooxygenase-2 in human gastric cancer. Cancer Res 57:1276-1280, 1997.
28. Rajnakowa A, Moochhala S, Goh PM, and Ngoi S. Expression of nitric oxide synthase, cyclooxygenase and p53 in different stage of human gastric cancer. Cancer Lett 172:177-185, 2001.
29. Fenoglio-Preiser CM. Gastrointestinal pathology. An Atlas and Text, ed 2. New York: Lippincott-Raven. 1998.
30. Maekawa M, Sugano K, Sano H, et al. Increased Cyclooxygenase-2 to -1 in human colorectal cancers and adenomas, but not in hyperplastic polyps. Jpn J Clin Oncol 28:421-426, 1998.
31. Yun CB, Lee BH, and Jang TJ. Expression of glucocorticoid receptors and cyclooxygenase-2 in nasal polyps from nonallergic patients. Ann Otol Rhinol Laryngol. 111(1):61-67, 2002.
32. Fernandez-Morata JC, Mullol J, Fuentes M, et al. Regulation of cyclooxygenase-1 and -2 expression in human nasal mucosa. Effects of cytokines and dexamethasone. Clin Exp Allergy. 30(9):1275-1284, 2000.
33. Liu CM, Hong CY, Shun CT, et al. Inducible cyclooxygenase and interleukin 6 gene expressions in nasal polyp fibroblasts: Possible implication in the pathogenesis of nasal polyposis. Arch Otolaryngol Head Neck Surg. 128(8):945-951, 2002.
34. Sousa A, Pfister R, Christie PE, et al. Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax. 52(11):940-945, 1997.
35. Bruynzeel PL, Kok PT, Hamelink ML, et al. Exclusive leukotriene C4 synthesis by purified human eosinophils induced by opsonized zymosan. FEBS Lett. 189(2):350-354, 1985.